$AVEX·8-K

AEVEX Corp. · Apr 20, 5:00 PM ET

Compare

AEVEX Corp. 8-K

Research Summary

AI-generated summary

Updated

AEVEX Corp. Completes IPO; Board Appointments and Charter Updates

What Happened AEVEX Corp. announced that its initial public offering closed on April 20, 2026. The company sold 16,000,000 firm shares of Class A common stock at $20.00 per share and the underwriters fully exercised a 30‑day option for an additional 2,400,000 shares; both the Firm Shares and Option Shares were delivered at closing. The underwriting was managed by Goldman Sachs, BofA Securities and Jefferies as lead representatives. Separate corporate governance steps were taken immediately prior to and following the IPO: five directors were appointed on April 16, 2026, and an amended and restated certificate of incorporation and bylaws became effective on April 17, 2026.

Key Details

  • IPO size and price: 16,000,000 firm shares at $20.00 per share; 2,400,000 option shares exercised — total 18,400,000 shares; gross proceeds of approximately $368 million (before fees and expenses).
  • Underwriters: Goldman Sachs & Co. LLC, BofA Securities, Inc. and Jefferies LLC served as representatives; the company agreed to customary indemnities for the underwriters.
  • Board changes: Bradley Feldmann, Matthew Klein, Brandon Levitan, Matthew Norton and Benjamin Spacapan were appointed to the board on April 16, 2026.
  • Governance documents: Amended and restated certificate of incorporation and bylaws were filed and became effective April 17, 2026.

Why It Matters The closing of the IPO is a major liquidity and capitalization event — it provides the company with significant capital (roughly $368M gross) and establishes AEVEX as a publicly traded company, which changes reporting, governance and shareholder dynamics. New board appointments and the amended charter/bylaws reflect the corporate governance structure expected for a public company and may affect future decision‑making and oversight. Investors should review the company’s prospectus and the attached underwriting and governance agreements for details on dilution, voting rights, indemnities, and any ongoing transaction terms described in the filing.

Loading document...